224 related articles for article (PubMed ID: 24586272)
1. Neurological and histological consequences induced by in vivo cerebral oxidative stress: evidence for beneficial effects of SRT1720, a sirtuin 1 activator, and sirtuin 1-mediated neuroprotective effects of poly(ADP-ribose) polymerase inhibition.
Gueguen C; Palmier B; Plotkine M; Marchand-Leroux C; Besson VC
PLoS One; 2014; 9(2):e87367. PubMed ID: 24586272
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
Singh N; Sharma G; Singh N; Hanif K
Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
[TBL] [Abstract][Full Text] [Related]
3. Deleterious activation of poly(ADP-ribose)polymerase-1 in brain after in vivo oxidative stress.
Besson VC; Margaill I; Plotkine M; Marchand-Verrecchia C
Free Radic Res; 2003 Nov; 37(11):1201-8. PubMed ID: 14703732
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: neuroprotection by 3-aminobenzamide.
Hortobágyi T; Görlach C; Benyó Z; Lacza Z; Hortobágyi S; Wahl M; Harkany T
Neuroscience; 2003; 121(4):983-90. PubMed ID: 14580948
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Aβ(1-42).
Bayrakdar ET; Armagan G; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
Cell Biochem Funct; 2014 Oct; 32(7):557-64. PubMed ID: 25111857
[TBL] [Abstract][Full Text] [Related]
6. Differing effects of the inhibition of poly(ADP-ribose) polymerase on the course of oxidative cell injury in hepatocytes and fibroblasts.
Yamamoto K; Tsukidate K; Farber JL
Biochem Pharmacol; 1993 Aug; 46(3):483-91. PubMed ID: 8347172
[TBL] [Abstract][Full Text] [Related]
7. High mobility group box-1 release from H
Ye TJ; Lu YL; Yan XF; Hu XD; Wang XL
World J Gastroenterol; 2019 Sep; 25(36):5434-5450. PubMed ID: 31576091
[TBL] [Abstract][Full Text] [Related]
8. Deleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat.
Besson VC; Croci N; Boulu RG; Plotkine M; Marchand-Verrecchia C
Brain Res; 2003 Oct; 989(1):58-66. PubMed ID: 14519512
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) polymerase-independent potentiation of nitrosourea cytotoxicity by 3-aminobenzamide in human malignant glioma cells.
Winter S; Weller M
Eur J Pharmacol; 2000 Jun; 398(2):177-83. PubMed ID: 10854828
[TBL] [Abstract][Full Text] [Related]
10. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.
Gupta S; Kaul CL; Sharma SS
Neurol Res; 2004 Jan; 26(1):103-7. PubMed ID: 14977067
[TBL] [Abstract][Full Text] [Related]
12. The neuroprotective effect of cerebral poly(ADP-ribose)polymerase inhibition in a rat model of global ischemia.
Plaschke K; Kopitz J; Weigand MA; Martin E; Bardenheuer HJ
Neurosci Lett; 2000 Apr; 284(1-2):109-12. PubMed ID: 10771174
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
Cuzzocrea S; Zingarelli B; Costantino G; Szabó A; Salzman AL; Caputi AP; Szabó C
Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
[TBL] [Abstract][Full Text] [Related]
14. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
Ding Y; Zhou Y; Lai Q; Li J; Gordon V; Diaz FG
Brain Res; 2001 Oct; 915(2):210-7. PubMed ID: 11595210
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase-1-induced NAD(+) depletion promotes nuclear factor-κB transcriptional activity by preventing p65 de-acetylation.
Kauppinen TM; Gan L; Swanson RA
Biochim Biophys Acta; 2013 Aug; 1833(8):1985-91. PubMed ID: 23597856
[TBL] [Abstract][Full Text] [Related]
16. Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase.
Yau L; Elliot T; Lalonde C; Zahradka P
Eur J Biochem; 1998 Apr; 253(1):91-100. PubMed ID: 9578465
[TBL] [Abstract][Full Text] [Related]
17. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.
Tokime T; Nozaki K; Sugino T; Kikuchi H; Hashimoto N; Ueda K
J Cereb Blood Flow Metab; 1998 Sep; 18(9):991-7. PubMed ID: 9740102
[TBL] [Abstract][Full Text] [Related]
18. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress.
Ren Y; Du C; Shi Y; Wei J; Wu H; Cui H
Int J Mol Med; 2017 May; 39(5):1317-1324. PubMed ID: 28339034
[TBL] [Abstract][Full Text] [Related]
19. Poly (ADP-ribose) polymerase-1 inhibitor, 3-aminobenzamide pretreatment ameliorates lipopolysaccharide-induced neurobehavioral and neurochemical anomalies in mice.
Sriram CS; Jangra A; Gurjar SS; Hussain MI; Borah P; Lahkar M; Mohan P; Bezbaruah BK
Pharmacol Biochem Behav; 2015 Jun; 133():83-91. PubMed ID: 25863272
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death.
Ying W; Sevigny MB; Chen Y; Swanson RA
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12227-32. PubMed ID: 11593040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
